TURNOVER (x1000 SEK)
NET PROFIT (x1000 SEK)
EMPLOYEES
Pharem Biotech AB
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
3,361
|
1,680
|
516 |
Financial expenses |
522
|
233
|
28 |
Earnings before taxes |
-4,593
|
-7,690
|
-6,312 |
EBITDA |
1,052
|
-2,188
|
-961 |
Total assets |
16,905
|
22,314
|
34,778 |
Current assets |
6,769
|
7,055
|
14,250 |
Current liabilities |
9,899
|
8,709
|
9,645 |
Equity capital |
7,006
|
8,517
|
16,207 |
- share capital |
107
|
104
![]() |
104 |
Employees (average) |
5
![]() |
5
|
3 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
41.4%
|
38.2%
|
46.6% |
Turnover per employee |
672
|
336
|
172 |
Profit as a percentage of turnover |
-136.7%
|
-457.7%
|
-1223.3% |
Return on assets (ROA) |
-24.1%
|
-33.4%
|
-18.1% |
Current ratio |
68.4%
|
81.0%
|
147.7% |
Return on equity (ROE) |
-65.6%
|
-90.3%
|
-38.9% |
Change turnover |
1,681
|
1,164
|
-365 |
Change turnover % |
100%
|
226%
|
-41% |
Chg. No. of employees |
0
|
2
|
-2 |
Chg. No. of employees % |
0%
|
67%
|
-40% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.